Gene therapy study identifies potential new treatment for liver cancer

Danmark Nyheder Nyheder

Gene therapy study identifies potential new treatment for liver cancer
Danmark Seneste Nyt,Danmark Overskrifter
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 51%

Gene therapy that induces the body to create microRNA-22 (miR-22), a naturally occurring molecule, successfully treated mice with hepatocellular carcinoma, the most common form of liver cancer.

," said Yu-Jui Yvonne Wan, senior author of the study. Wan is a distinguished professor and vice chair for research in the UC Davis Department of Pathology and Laboratory Medicine."The study's findings suggest that miR-22 therapy could provide better survival outcomes, enhance anti-tumor immunity, improve metabolism and reduce inflammation."for Wan's discovery of miR-22 for treating hepatic and metabolic diseases. The patent is currently pending.

When people have colon or liver cancer, signaling from these metabolites is reduced, which in turn reduces miR-22. Both miR-22 and lenvatinib inhibited the progression of the liver cancer compared to untreated mice. However, the miR-22-treated mice had longer survival times without toxicity compared with lenvatinib-treated mice. Some of the study's key findings:

Vi har opsummeret denne nyhed, så du kan læse den hurtigt. Hvis du er interesseret i nyheden, kan du læse hele teksten her. Læs mere:

medical_xpress /  🏆 101. in UK

Danmark Seneste Nyt, Danmark Overskrifter

Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.

New study sheds light on the molecular mechanisms underlying SLC29A3 disordersNew study sheds light on the molecular mechanisms underlying SLC29A3 disordersIn humans, the SLC29A3 gene regulates the function of lysosomes to control waste recycling in cells such as macrophages (that engulf and destroy foreign bodies). This gene encodes for the lysosomal protein that transport nucleosides—degradation products of RNA and DNA—from lysosomes to the cytoplasm. Loss-of-function mutations in the SLC29A3 gene lead to aberrant nucleoside storage, resulting in a spectrum of conditions called SLC29A3 disorders.
Læs mere »

Study connects neural gene expression differences to functional distinctionsStudy connects neural gene expression differences to functional distinctionsFiguring out how hundreds of different kinds of brain cells develop from their unique expression of thousands of genes promises to not only advance understanding of how the brain works in health, but also what goes wrong in disease. A new MIT study that precisely probes this 'molecular logic' in two neuron types of the Drosophila fruit fly, shows that even similar cells push and pull many levers to develop distinct functions.
Læs mere »

New gene variant linked to Parkinson's disease found in people of African ancestryNew gene variant linked to Parkinson's disease found in people of African ancestryA gene variant found almost exclusively in the genomes of people of African ancestry increases the risk of developing Parkinson's disease, according to an international study of nearly 198,000 participants with this genetic background.
Læs mere »

Naked mole rat gene boosts health and longevity in miceNaked mole rat gene boosts health and longevity in miceIn a groundbreaking endeavor, researchers at the University of Rochester have successfully transferred a longevity gene from naked mole rats to mice, resulting in improved health and an extension of the mouse's lifespan.
Læs mere »

Parkinson's disease gene variant found in some people of African ancestryParkinson's disease gene variant found in some people of African ancestryA gene variant found almost exclusively in the genomes of people of African ancestry increases the risk of developing Parkinson's disease, according to an international study of nearly 198,000 participants with this genetic background. Published in The Lancet Neurology, the study results suggest the risk may be linked to a variant in the gene encoding β-glucocerebrosidase (GBA1), a protein known to control how cells in the body recycle proteins.
Læs mere »

Waters launches XBridge Premier GTx BEH SEC columns for gene therapy applicationsWaters launches XBridge Premier GTx BEH SEC columns for gene therapy applicationsWaters Corporation introduced the first in a new line of size exclusion chromatography (SEC) columns aimed at improving the analysis while lowering the cost of gene therapies, specifically adeno-associated viral (AAV) vectors.
Læs mere »



Render Time: 2025-03-22 01:23:20